October 23, 2026 02:05 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Tiger Shroff, not Salman Khan, was the main target, probe reveals shocking details | Dammam airport attack: Indian killed, two compatriots injured as Saudi Arabia faces fresh strikes | ‘Among others’: Macron takes swipe at Trump over France unrest, calls foreign leaders’ remarks ‘stupid’ | ‘Specific threat-related inputs’: Delhi Police blocks Diljit Dosanjh’s Delhi concert | ‘Barbaad kare alfaz mere’: Ranbir Kapoor apologises for Dussehra gaffe in Kolkata | Delhi court releases CJP's Saurav Das and Ashutosh Ranka after 7 days in custody | ‘We are seeing what is happening outside our country’: Delhi HC judge’s remark as CJP leaders Saurav Das and Ashutosh Ranka withdraw custody plea | Salman Khan was the original target? Tiger Shroff firing probe reveals shocking twist | ‘UN experts are an oxymoron’: Marco Rubio takes swipe at UN, refuses to comment on India's protests | ‘US ties with no country come at India's expense’: Marco Rubio addresses concerns over Pakistan, China
Stock Market
Representational Photo: ChatGPT

Market update: Sensex tumbles 120 points, Nifty below 25,850 at closing bell

| @indiablooms | Dec 17, 2025, at 04:00 pm

Mumbai/IBNS: The Indian stock market ended Wednesday on a negative note, with BSE Sensex falling 120 points and NSE Nifty 50 closing below 25,850. Sensex settled at 84,559.65, while Nifty finished at 25,818.55.

Among sector movers, HDFC Bank, ICICI Bank, Asian Paints, and Titan were top losers, while shares of Maruti, TCS, Tata Steel, Reliance, and Bharti Airtel witnessed gains.

The Indian rupee, which opened at a fresh low, rebounded to settle at ₹90.38 against the US dollar, marking a 0.7% gain—the biggest single-day rise since October 15.

Meanwhile, dialysis service provider Nephrocare Health Services made a strong stock market debut, listing at a premium of about 7%. The shares debuted at ₹491.70 on the BSE (6.8% premium) and ₹490 on the NSE (6.52% premium), according to CNBC-TV18.

Nephrocare’s ₹871.05-crore initial public offering (IPO), open for subscription from December 10–12, was oversubscribed 13.96 times, highlighting strong investor demand.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.